PHP
VSTM icon

Parkman Healthcare Partners’s Verastem VSTM Stock Holding History

Parkman Healthcare Partners’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,896
Closed -$269K – 88
2022
Q1 		$269K Buy
15,896
+618
+4% +$10.6K 0.08% 80
2021
Q4 		$376K Buy
15,278
+628
+4% +$19.8K 0.08% 84
2021
Q3 		$541K Buy
14,650
+4,167
+40% +$153K 0.14% 72
2021
Q2 		$512K Buy
+10,483
New +$437K 0.11% 79
2021
Q1 		– Sell
-20,954
Closed -$536K – 97
2020
Q4 		$536K Buy
+20,954
New +$421K 0.14% 80

Other funds holding VSTM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Parkman Healthcare Partners's VSTM Position: Q2 2022 in Review

Parkman Healthcare Partners sold out of Verastem (VSTM) in Q2 2022, closing a stake of 15,896 shares — an estimated $269K sold.

Parkman Healthcare Partners first reported a position in VSTM in Q4 2020 and held it in 5 quarters. The position peaked at $541K in Q3 2021. 122 funds tracked by Wall St. Rank hold VSTM as of Q2 2022.

  • Parkman Healthcare Partners reported no remaining Verastem position as of Q2 2022 after selling out during the quarter.
  • Parkman Healthcare Partners sold 15,896 Verastem shares in Q2 2022, an estimated $269K.
  • Parkman Healthcare Partners first reported a position in Verastem in Q4 2020 and held it in 5 quarters.
  • Parkman Healthcare Partners's Verastem position peaked at $541K in Q3 2021.
  • 122 funds tracked by Wall St. Rank held Verastem as of Q2 2022.

Based on Parkman Healthcare Partners's 13F filing for Q2 2022, filed 12 Aug 2022.